UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adoptive cell therapy for the treatment of patients with metastatic melanoma

Current opinion in immunology, 2009-04, Vol.21 (2), p.233-240

2009

Volltextzugriff (PDF)

Adoptive-cell-transfer therapy for the treatment of patients with cancer

Nature reviews. Cancer, 2003-09, Vol.3 (9), p.666-675

2003

Volltextzugriff (PDF)

Cancer Regression in Patients with Metastatic Melanoma after the Transfer of Autologous Antitumor Lymphocytes

Proceedings of the National Academy of Sciences - PNAS, 2004-10, Vol.101 (Suppl 2), p.14639-14645

2004

Volltextzugriff (PDF)

Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma

Journal of clinical oncology, 2005-04, Vol.23 (10), p.2346-2357

2005

Volltextzugriff (PDF)

A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma

Clinical cancer research, 2017-01, Vol.23 (2), p.351-362

2017

Volltextzugriff (PDF)

Simplified method of the growth of human tumor infiltrating lymphocytes in gas-permeable flasks to numbers needed for patient treatment

Journal of immunotherapy (1997), 2012-04, Vol.35 (3), p.283-292

2012

Volltextzugriff (PDF)

Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapy

Journal of immunotherapy, 2008-10, Vol.31 (8), p.742-751

2008

Volltextzugriff (PDF)

Cutting Edge: Persistence of Transferred Lymphocyte Clonotypes Correlates with Cancer Regression in Patients Receiving Cell Transfer Therapy

The Journal of immunology (1950), 2004-12, Vol.173 (12), p.7125-7130

2004

Volltextzugriff (PDF)

Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients

Journal of immunotherapy (1997), 2003-07, Vol.26 (4), p.332-342

2003

Volltextzugriff (PDF)

Tumor-specific CD4+ melanoma tumor-infiltrating lymphocytes

Journal of immunotherapy (1997), 2012-06, Vol.35 (5), p.400

2012

Volltextzugriff (PDF)

Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy

Blood, 2005-01, Vol.105 (1), p.241-250

2005

Volltextzugriff (PDF)

Cancer Regression and Autoimmunity in Patients after Clonal Repopulation with Antitumor Lymphocytes

Science (American Association for the Advancement of Science), 2002-10, Vol.298 (5594), p.850-854

2002

Volltextzugriff (PDF)

Tumor infiltrating lymphocyte therapy for metastatic melanoma: analysis of tumors resected for TIL

Journal of immunotherapy, 2010-10, Vol.33 (8), p.840-847

2010

Volltextzugriff (PDF)

Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy

Journal of immunotherapy (1997), 2005-01, Vol.28 (1), p.53-62

2005

Volltextzugriff (PDF)

The stoichiometric production of IL-2 and IFN-γ mRNA defines memory T cells that can self-renew after adoptive transfer in humans

Science translational medicine, 2012-08, Vol.4 (149), p.149ra120

2012

Volltextzugriff (PDF)

Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions

Human gene therapy, 2005-04, Vol.16 (4), p.457-472

2005

Volltextzugriff (PDF)

Enrichment of CD8+ cells from melanoma tumor-infiltrating lymphocyte cultures reveals tumor reactivity for use in adoptive cell therapy

Journal of immunotherapy, 2010-06, Vol.33 (5), p.547-556

2010

Volltextzugriff (PDF)

High Avidity CTLs for Two Self-Antigens Demonstrate Superior In Vitro and In Vivo Antitumor Efficacy

The Journal of immunology (1950), 1999-01, Vol.162 (2), p.989-994

1999

Volltextzugriff (PDF)

Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression

Journal of immunotherapy (1997), 2005-05, Vol.28 (3), p.258-267

2005

Volltextzugriff (PDF)

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

Nature medicine, 1998-03, Vol.4 (3), p.321-327

1998

Volltextzugriff (PDF)

High Efficiency TCR Gene Transfer into Primary Human Lymphocytes Affords Avid Recognition of Melanoma Tumor Antigen Glycoprotein 100 and Does Not Alter the Recognition of Autologous Melanoma Antigens

The Journal of immunology (1950), 2003-09, Vol.171 (6), p.3287-3295

2003

Volltextzugriff (PDF)

Evaluation of γ-retroviral vectors that mediate the inducible expression of IL-12 for clinical application

Journal of immunotherapy (1997), 2012-06, Vol.35 (5), p.430-439

2012

Volltextzugriff (PDF)

A simplified method for the clinical-scale generation of central memory-like CD8+ T cells after transduction with lentiviral vectors encoding antitumor antigen T-cell receptors

Journal of immunotherapy, 2010-07, Vol.33 (6), p.648-658

2010

Volltextzugriff (PDF)

Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma

Journal of immunotherapy (1997), 2001-07, Vol.24 (4), p.363-373

2001

Volltextzugriff (PDF)

A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma

Journal of immunotherapy (1997), 2002-05, Vol.25 (3), p.243-251

2002

Volltextzugriff (PDF)

1 – 25 von 362

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(254)
Mit Volltextzugriff
(287)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adoptive cell therapy for the treatment of patients with metastatic melanoma

Adoptive-cell-transfer therapy for the treatment of patients with cancer

Cancer Regression in Patients with Metastatic Melanoma after the Transfer of Autologous Antitumor Lymphocytes

Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma

A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma

Simplified method of the growth of human tumor infiltrating lymphocytes in gas-permeable flasks to numbers needed for patient treatment

Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapy

Cutting Edge: Persistence of Transferred Lymphocyte Clonotypes Correlates with Cancer Regression in Patients Receiving Cell Transfer Therapy

Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients

Tumor-specific CD4+ melanoma tumor-infiltrating lymphocytes

Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy

Cancer Regression and Autoimmunity in Patients after Clonal Repopulation with Antitumor Lymphocytes

Tumor infiltrating lymphocyte therapy for metastatic melanoma: analysis of tumors resected for TIL

Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy

The stoichiometric production of IL-2 and IFN-γ mRNA defines memory T cells that can self-renew after adoptive transfer in humans

Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions

Enrichment of CD8+ cells from melanoma tumor-infiltrating lymphocyte cultures reveals tumor reactivity for use in adoptive cell therapy

High Avidity CTLs for Two Self-Antigens Demonstrate Superior In Vitro and In Vivo Antitumor Efficacy

Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

High Efficiency TCR Gene Transfer into Primary Human Lymphocytes Affords Avid Recognition of Melanoma Tumor Antigen Glycoprotein 100 and Does Not Alter the Recognition of Autologous Melanoma Antigens

Evaluation of γ-retroviral vectors that mediate the inducible expression of IL-12 for clinical application

A simplified method for the clinical-scale generation of central memory-like CD8+ T cells after transduction with lentiviral vectors encoding antitumor antigen T-cell receptors

Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma

A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma

Suchergebnisse filtern